The Current Ratio of Ligand Pharmaceuticals Incorporated (LGND) is
22.23.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
22.23
|
| 2024-12-31 |
8.93
|
| 2023-12-31 |
14.15
|
| 2022-12-31 |
2.67
|
| 2021-12-31 |
11.15
|
| 2020-12-31 |
5.00
|
| 2019-12-31 |
66.09
|
| 2018-12-31 |
10.59
|
| 2017-12-31 |
0.99
|
| 2016-12-31 |
0.72
|
| Ticker |
Name |
Value |
|
GBT
|
Global Blood Therapeutics Inc
|
9.11
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
3.14
|
|
BLUE
|
Genetix Biotherapeutics Inc
|
0.48
|
|
DRNA
|
Dicerna Pharmaceuticals Inc
|
3.48
|
|
FOLD
|
Amicus Therapeutics Inc
|
2.84
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
RUBY
|
Rubius Therapeutics Inc
|
2.56
|
|
AMTI
|
Applied Molecular Transport Inc.
|
4.24
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
10.47
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
RCUS
|
Arcus Biosciences, Inc.
|
4.36
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
10.25
|
|
MYOV
|
Myovant Sciences Ltd
|
1.95
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
RVMD
|
Revolution Medicines, Inc.
|
7.14
|
|
ADCT
|
Adc Therapeutics Ltd
|
4.37
|
|
IMCR
|
Immunocore Holdings PLC
|
4.04
|
|
INO
|
Inovio Pharmaceuticals Inc
|
1.40
|
|
MCRB
|
Seres Therapeutics, Inc.
|
2.56
|
|
BCAB
|
Bioatla Inc
|
0.37
|
|
DCPH
|
Deciphera Pharmaceuticals Inc
|
3.80
|
|
IMGN
|
ImmunoGen Inc
|
2.49
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
LEGN
|
Legend Biotech Corporation
|
1.96
|
|
SGMO
|
Sangamo Therapeutics Inc
|
0.84
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
3.81
|
|
VIE
|
Viela Bio Inc
|
8.45
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
FGEN
|
FibroGen Inc
|
1.47
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
IGMS
|
IGM Biosciences LLC
|
5.11
|
|
ALXO
|
ALX Oncology Holdings Inc
|
7.05
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
1.99
|